1,638
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Effect of in vitro simulated digestion on the anti-Helicobacter Pylori activity of different Propolis extracts

ORCID Icon, , , , &
Article: 2183810 | Received 30 Sep 2022, Accepted 15 Feb 2023, Published online: 14 Mar 2023

References

  • Suerbaum S, Josenhans C. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol. 2007;5(6):441–452.
  • Logan RP, Walker MM. ABC of the upper gastrointestinal tract: epidemiology and diagnosis of Helicobacter pylori infection. BMJ. 2001;323(7318):920–922.
  • Boreiri M, Samadi F, Etemadi A, Babaei M, Ahmadi E, Sharifi AH, Nikmanesh A, Houshiar A, Pourfarzai F, Yazdanbod A, et al. Gastric cancer mortality in a high incidence area: long-term follow-up of Helicobacter pylori-related precancerous lesions in the general population. Arch Iran Med. 2013;16(6):343–347.
  • Manente L, Perna A, Buommino E, Altucci L, Lucariello A, Citro G, Baldi A, Iaquinto G, Tufano MA, De Luca A. The Helicobacter pylori’s protein VacA has direct effects on the regulation of cell cycle and apoptosis in gastric epithelial cells. J Cell Physiol. 2008;214(3):582–587.
  • Perrais M, Rousseaux C, Ducourouble M-P, Courcol R, Vincent P, Jonckheere N, Van Seuningen I. Helicobacter pylori urease and flagellin alter mucin gene expression in human gastric cancer cells. Gastric Cancer. 2014;17(2):235–246.
  • Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun. 1991;59(7):2470–2475.
  • Olivera-Severo D, Uberti AF, Marques MS, Pinto MT, Gomez-Lazaro M, Figueiredo C, Leite M, Carlini CR. A new role for Helicobacter pylori urease: contributions to angiogenesis. Front Microbiol. 2017;8:1883.
  • Song W-Q, Liu M-L, Li S-Y, Xiao Z-P. Recent efforts in the discovery of urease inhibitor identifications. Curr Top Med Chem. 2022;22(2):95–107.
  • Kosikowska P, Berlicki Ł. Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. Expert Opin Ther Pat. 2011;21(6):945–957.
  • Amtul Z, Rahman A-U, Siddiqui RA, Choudhary MI. Chemistry and mechanism of urease inhibition. Curr Med Chem. 2002;9(14):1323–1348.
  • Pope AJ, Toseland CD, Rushant B, Richardson S, McVey M, Hills J. Effect of potent urease inhibitor, fluorofamide, on Helicobacter sp. in vivo and in vitro. Dig Dis Sci. 1998;43(1):109–119.
  • Kataria R, Khatkar A. In-silico designing, ADMET analysis, synthesis and biological evaluation of novel derivatives of diosmin against urease protein and Helicobacter pylori bacterium. Curr Top Med Chem. 2019;19(29):2658–2675.
  • Paun G, Litescu SC, Neagu E, Tache A, Lucian Radu G. Evaluation of Geranium spp., Helleborus spp. and Hyssopus spp. polyphenolic extracts inhibitory activity against urease and α-chymotrypsin. J Enzyme Inhib Med Chem. 2014;29(1):28–34.
  • Ndemangou B, Sielinou VT, Vardamides JC, Ali MS, Lateef M, Iqbal L, Afza N, Nkengfack AE. Urease inhibitory isoflavonoids from different parts of Calopogonium mucunoides (Fabaceae). J Enzyme Inhib Med Chem. 2013;28(6):1156–1161.
  • Tariq SA, Ahmad MN, Khan A, Choudhary MI, Ahmad W, Ahmad M., Obaidullah M. Urease inhibitors from Indigofera gerardiana Wall. J Enzyme Inhib Med Chem. 2011;26(4):480–484.
  • Arfan M, Ali M, Ahmad H, Anis I, Khan A, Choudhary MI, Shah MR. Urease inhibitors from Hypericum oblongifolium WALL. J Enzyme Inhib Med Chem. 2010;25(2):296–299.
  • Ferheen S, Afza N, Malik A, Iqbal L, Azam Rasool M, Irfan Ali M, Bakhsh Tareen R. Galinsosides A and B, bioactive flavanone glucosides from Galinsoga parviflora. J Enzyme Inhib Med Chem. 2009;24(5):1128–1132.
  • Sahin H. Honey as an apitherapic product: its inhibitory effect on urease and xanthine oxidase. J Enzyme Inhib Med Chem. 2016;31(3):490–494.
  • Kolayli S, Can Z, Yildiz O, Sahin H, Karaoglu SA. A comparative study of the antihyaluronidase, antiurease, antioxidant, antimicrobial and physicochemical properties of different unifloral degrees of chestnut (Castanea sativa Mill.) honeys. J Enzyme Inhib Med Chem. 2016;31(sup3):96–104.
  • Saleem N, Howden CW. Update on the management of Helicobacter pylori infection. Curr Treat Options Gastroenterol. 2020;18(3):476–487.
  • Kim SY, Choi DJ, Chung J-W. Antibiotic treatment for Helicobacter pylori: is the end coming? World J Gastrointest Pharmacol Ther. 2015;6(4):183–198.
  • McGee DJ, Mobley HL. Pathogenesis of Helicobacter pylori infection. Curr Opin Gastroenterol. 2000;16(1):24–31.
  • Luca C, Kharaeva Z, Korkina L. Is there a role for antioxidants in the prevention of infection-associated carcinogenesis and in the treatment of infection-driven tumors? CTMC. 2015;15(2):120–135.
  • Bonifácio BV, dos Santos Ramos MA, da Silva PB, Bauab TM. Antimicrobial activity of natural products against Helicobacter pylori: a review. Ann Clin Microbiol Antimicrob. 2014;13:54.
  • Xu C, Ruan X-M, Li H-S, Guo B-X, Ren X-D, Shuang J-L, Zhang Z. Anti-adhesive effect of an acidic polysaccharide from Aloe vera L. var. chinensis (Haw.) Berger on the binding of Helicobacter pylori to the MKN-45 cell line. J Pharm Pharmacol. 2010;62(12):1753–1759.
  • Sivam GP. Protection against Helicobacter pylori and other bacterial infections by garlic. J Nutr. 2001;131(3s):1106S–8S.
  • Haristoy X, Fahey JW, Scholtus I, Lozniewski A. Evaluation of the antimicrobial effects of several isothiocyanates on Helicobacter pylori. Planta Med. 2005;71(4):326–330.
  • Zhou Y, Taylor B, Smith TJ, Liu Z-P, Clench M, Davies NW, Rainsford KD. A novel compound from celery seed with a bactericidal effect against Helicobacter pylori. J Pharm Pharmacol. 2009;61(8):1067–1077.
  • Asha MK, Debraj D, Prashanth D, Edwin JR, Srikanth HS, Muruganantham N, Dethe SM, Anirban B, Jaya B, Deepak M, et al. In vitro anti-Helicobacter pylori activity of a flavonoid rich extract of Glycyrrhiza glabra and its probable mechanisms of action. J Ethnopharmacol. 2013;145(2):581–586.
  • Biagi M, Miraldi E, Figura N, Giachetti D. Antiradical activity and in vitro inhibition of Helicobacter pylori by Italian red wines. Nat Prod Commun. 2009;4(2):255–260.
  • Kataria R, Khatkar A. Resveratrol in various pockets: a review. Curr Top Med Chem. 2019;19(2):116–122.
  • Elkousy RH, Mostafa NM, Abd-Alkhalek AM, El Hassab MA, Al-Rashood ST, Eldehna WM, Eldahshan OA. GC/MS analysis and potential synergistic effect of mandarin and marjoram oils on Helicobacter pylori. J Enzyme Inhib Med Chem. 2022;37(1):1610–1619.
  • Bae EA, Han MJ, Kim DH. In vitro anti-Helicobacter pylori activity of some flavonoids and their metabolites. Planta Med. 1999;65(5):442–443.
  • Shin J-E, Kim J-M, Bae E-A, Hyun Y-J, Kim D-H. In vitro inhibitory effect of flavonoids on growth, infection and vacuolation of Helicobacter pylori. Planta Med. 2005;71(3):197–201.
  • Grande R, Carradori S, Puca V, Vitale I, Angeli A, Nocentini A, Bonardi A, Gratteri P, Lanuti P, Bologna G, et al. Selective inhibition of Helicobacter pylori carbonic anhydrases by carvacrol and thymol could impair biofilm production and the release of outer membrane vesicles. IJMS. 2021;22(21):11583.
  • Huang S, Zhang C-P, Wang K, Li GQ, Hu F-L. Recent advances in the chemical composition of propolis. Molecules. 2014;19(12):19610–19632.
  • Omene C, Kalac M, Wu J, Marchi E, Frenkel K, O’Connor OA. Propolis and its active component, caffeic acid phenethyl ester (CAPE), modulate breast cancer therapeutic targets via an epigenetically mediated mechanism of action. J Cancer Sci Ther. 2013;5(10):334–342. https://pubmed.ncbi.nlm.nih.gov/24466386.
  • Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med. 2013;2013:697390.
  • Governa P, Cusi MG, Borgonetti V, Sforcin JM, Terrosi C, Baini G, Miraldi E, Biagi M. Beyond the biological effect of a chemically characterized poplar propolis: antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells. Biomedicines. 2019;7(4):73.
  • Boukraâ L, Sulaiman SA. Rediscovering the antibiotics of the hive. Recent Pat Antiinfect Drug Discov. 2009;4(3):206–213.
  • Haghdoost NS, Salehi TZ, Khosravi A, Sharifzadeh A. Antifungal activity and influence of propolis against germ tube formation as a critical virulence attribute by clinical isolates of Candida albicans. J Mycol Med. 2016;26(4):298–305.
  • Mirzoeva OK, Grishanin RN, Calder PC. Antimicrobial action of propolis and some of its components: the effects on growth, membrane potential and motility of bacteria. Microbiol Res. 1997;152(3):239–246.
  • Speciale A, Costanzo R, Puglisi S, Musumeci R, Catania MR, Caccamo F, Iauk L. Antibacterial activity of propolis and its active principles alone and in combination with macrolides, beta-lactams and fluoroquinolones against microorganisms responsible for respiratory infections. J Chemother. 2006;18(2):164–171.
  • Ripari N, Sartori AA, da Silva Honorio M, Conte FL, Tasca KI, Santiago KB, Sforcin JM. Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment. J Pharm Pharmacol. 2021;73(3):281–299.
  • Viuda-Martos M, Ruiz-Navajas Y, Fernández-López J, Pérez-Alvarez JA. Functional properties of honey, propolis, and royal jelly. J Food Sci. 2008;73(9):R117–24.
  • Armutcu F, Akyol S, Ustunsoy S, Turan FF. Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects (review). Exp Ther Med. 2015;9(5):1582–1588.
  • Lee HN, Shin SA, Choo GS, Kim HJ, Park YS, Kim BS, Kim SK, Cho SD, Nam JS, Choi CS, et al. Anti‑inflammatory effect of quercetin and galangin in LPS‑stimulated RAW264.7 macrophages and DNCB‑induced atopic dermatitis animal models. Int J Mol Med. 2018;41(2):888–898.
  • Zhao D, Liu Z, Ding J, Li W, Sun Y, Yu H, Zhou Y, Zeng J, Chen C, Jia J. Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J Med Microbiol. 2010;59(Pt 3):259–265.
  • Sun C, Wu Z, Wang Z, Zhang H. Effect of ethanol/water solvents on phenolic profiles and antioxidant properties of beijing propolis extracts. Evid Based Complement Alternat Med. 2015;2015:595393.
  • Baltas N, Karaoglu SA, Tarakci C, Kolayli S. Effect of propolis in gastric disorders: inhibition studies on the growth of Helicobacter pylori and production of its urease. J Enzyme Inhib Med Chem. 2016;31(sup2):46–50.
  • Biagi M, Miraldi E, Figura N, Magnano AR, Ierardi G, Manca D, Corsini M, Barlozzini B, Mannari C, Stiaccini G, et al. Gastroprotective and anti Helicobacter pylori activities of propolis. Planta Med. 2011;77(12):PM75.
  • Governa P, Manetti F, Miraldi E, Biagi M. Effects of in vitro simulated digestion on the antioxidant activity of different Camellia sinensis (L.) Kuntze leaves extracts. Eur Food Res Technol. 2022;248(1):119–128.
  • Governa P, Biagi M. Copaifera langsdorffii Desf.: in vitro investigation on anti- Helicobacter pylori and anti-inflammatory activities of oleoresin and fruit methanolic extract. Plant Biosyst an Int J Deal with All Asp Plant Biol. 2020;154(1):117–124.
  • Berthelot MP. Berthelot’s Reaction Mechanism. Rep Chim Appl. 1859;1:2884.
  • Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein data bank. Nucleic Acids Res. 2000;28(1):235–242.
  • Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791.
  • Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11(5):905–919.
  • Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron. 1980;36(22):3219–3228.
  • Sterling T, Irwin JJ. ZINC 15–Ligand discovery for everyone. J Chem Inf Model. 2015;55(11):2324–2337.
  • O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3(1):33.
  • Xiao Z-P, Wang X-D, Peng Z-Y, Huang S, Yang P, Li Q-S, Zhou L-H, Hu X-J, Wu L-J, Zhou Y, et al. Molecular docking, kinetics study, and structure-activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors. J Agric Food Chem. 2012;60(42):10572–10577.
  • Olegário LS, Andrade JKS, Andrade GRS, Denadai M, Cavalcanti RL, da Silva MAAP, Narain N. Chemical characterization of four Brazilian brown propolis: an insight in tracking of its geographical location of production and quality control. Food Res Int. 2019;123:481–502.
  • He M, Wu T, Pan S, Xu X. Antimicrobial mechanism of flavonoids against Escherichia coli ATCC 25922 by model membrane study. Appl Surf Sci. 2014;305:515–521.
  • Skiba MA, Szendzielorz K, Mazur B, Król W. The inhibitory effect of flavonoids on interleukin-8 release by human gastric adenocarcinoma (AGS) cells infected with cag PAI (+) Helicobacter pylori. Cent Eur J Immunol. 2016;41(3):229–235.
  • Zhu X, Li R, Wang C, Zhou S, Fan Y, Ma S, Gao D, Gai N, Yang J. Pinocembrin inhibits the proliferation and metastasis of breast cancer via suppression of the PI3K/AKT signaling pathway. Front Oncol. 2021;11:661184.
  • Romero M, Freire J, Pastene E, García A, Aranda M, González C. Propolis polyphenolic compounds affect the viability and structure of Helicobacter pylori in vitro. Rev Bras Farmacogn. 2019;29(3):325–332.
  • Adebisi AO, Laity PR, Conway BR. Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori. J Pharm Pharmacol. 2015;67(4):511–524.
  • Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I, Kelly CP, Ewoldt RH, McKinley GH, So P, Erramilli S, et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci U S A. 2009;106(34):14321–14326.
  • Kafarski P, Talma M. Recent advances in design of new urease inhibitors: a review. J Adv Res. 2018;13:101–112.
  • Baltas N, Yildiz O, Kolayli S. Inhibition properties of propolis extracts to some clinically important enzymes. J Enzyme Inhib Med Chem. 2016;31(sup1):52–55.